Company page
Biohaven Ltd.
Biohaven Ltd. is a public company traded under the ticker BHVN in the American market. The company has a market capitalization of approximately $2.34 billion. Biohaven focuses on developing innovative therapies for neurological diseases, aiming to improve patient outcomes.
- Ticker
- BHVN:NYSE
- Asset type
- Stock
- Market cap
- $2.03B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE
- Currency
- USD